A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer

Summary

To demonstrate whether addition of MM-121 to paclitaxel is more effective than treatment with paclitaxel alone, when administered as part of the neoadjuvant treatment in Her2 negative locally advanced operable breast cancer patients.

Timeline

Start

2011-08

Primary completion

2013-12

Completion

2014-06

Drugs

Indications